NEW YORK (GenomeWeb) – Thermo Fisher Scientific said today that its board of directors has approved a new $1 billion share repurchase program.

Concurrently, the company also announced a $.15 per share quarterly dividend.

The repurchase authorization allows Thermo Fisher to buy $1 billion of its common stock in both the open market and through negotiated transactions, and replaces an existing authorization that had roughly $410 million remaining. Thermo Fisher said that it intends to begin repurchasing its stock in 2016. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.